Weekly Roundup: May 18, 2019


Max Rex

Episode Description

This week, the team discuss the deal between UK’s National Health Service and Biogen prompting the successful reimbursement of Biogen’s Spinraza as a treatment for spinal muscular atrophy and Solid Biosciences’ clinical update on its Duchenne Muscular Dystrophy gene therapy product SGT-001.

Presenter : Aparna Krishnan

Contributor: Max Rex

Producer: Aparna Krishnan

Latest episodes

Share this podcast